Vivera Pharmaceuticals has a total of 25 patents globally, out of which 6 have been granted. Of these 25 patents, more than 84% patents are active. The United States of America is where Vivera Pharmaceuticals has filed the maximum number of patents, followed by Australia, Canada and United Kingdom. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vivera Pharmaceuticals.
Vivera Pharmaceuticals was founded in 2018. Vivera Pharmaceuticals is a biopharmaceutical organization. The company offers advanced diagnostics, medical supplies, pharmaceuticals, medical devices, medical technologies, and neurosciences.
Do read about some of the most popular patents of Vivera Pharmaceuticals which have been covered by us in this article and also you can find Vivera Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vivera Pharmaceuticals patent portfolio.
How many patents does Vivera Pharmaceuticals have?
Vivera Pharmaceuticals has a total of 25 patents globally. These patents belong to 5 unique patent families. Out of 25 patents, 21 patents are active.
How Many Patents did Vivera Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vivera Pharmaceuticals Applications Filed | Vivera Pharmaceuticals Patents Granted |
| 2023 | – | 2 |
| 2022 | 4 | 2 |
| 2021 | 9 | 2 |
| 2020 | 6 | – |
| 2019 | 5 | – |
| 2018 | 1 | – |
How many Vivera Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Vivera Pharmaceuticals File in Different Countries?
Countries in which Vivera Pharmaceuticals Filed Patents
| Country | Patent |
| United States Of America | 16 |
| Australia | 2 |
| Canada | 2 |
| United Kingdom | 2 |
| Israel | 1 |
Where are Research Centers of Vivera Pharmaceuticals Patents Located?
The Research Center of Vivera Pharmaceuticals is in the United States of America.
Best Vivera Pharmaceuticals Patent
US20230104820A1 is the most popular patent in the Vivera Pharmaceuticals portfolio. It has received 1 citation so far from company like PrinterPrezz.
What Percentage of Vivera Pharmaceuticals US Patent Applications Were Granted?
Vivera Pharmaceuticals (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100%.
Below are the key stats of Vivera Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Vivera Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Genius Patent Apc | 12 | 100% |
List of Vivera Pharmaceuticals patents
| Vivera Pharmaceuticals Patents | Title |
| US11594149B1 | Speech Fluency Evaluation And Feedback |
| US11450420B2 | Secure Smart Dosing System With Automated Delivery, Measurement, And Management For Pills |
| US11406728B2 | Self-Contained, Portable, Sanitization Device And Telemedicine Station |
| US11090449B2 | Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management |
| US11083850B2 | Secure Smart Dosing System With Automated Delivery, Measurement, And Management |
| US20230114360A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Zicronapine |
| US20230104820A1 | Self-Contained, Portable, Sanitization Device And Telemedicine Station |
| US20220168226A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Metformin |
| US20220117900A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Vortioxetine |
| US20220117901A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Brexpiprazole |
| US20220096387A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Lurasidone |
| US20220062189A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Sildenafil Citrate |
| US20220023223A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Blonanserin |
| US20210401758A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Trazodone |
| US20210401757A1 | Sublingual Delivery For Mitigation Of Side Effects Associated With Olanzapine And Metformin |
| GB2591888B | Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management |
| GB2602413A | Secure Smart Dosing System With Automated Delivery, Measurement, And Management |
| CA3151052A1 | Secure Smart Dosing System With Automated Delivery, Measurement, And Management |
| CA3110239A1 | Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management |
| AU2020346957A1 | Secure Smart Dosing System With Automated Delivery, Measurement, And Management |
| IL291319A | Secure Smart Dosing System With Automated Delivery, Measurement, And Management |
| US20210311056A1 | Self-Administered Infection Testing And Result Determination |
| WO2021051001A1 | Secure Smart Dosing System With Automated Delivery, Measurement, And Management |
| WO2020041430A1 | Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management |
| AU2019325522A1 | Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management |
What are Vivera Pharmaceuticals key innovation segments?
What Technologies are Covered by Vivera Pharmaceuticals?
The chart below distributes patents filed by Vivera Pharmaceuticals